RU93048539A - Производные оксазолидина, обладающие противодиабетическими свойствами и действием против ожирения, их получение и терапевтическое применение - Google Patents

Производные оксазолидина, обладающие противодиабетическими свойствами и действием против ожирения, их получение и терапевтическое применение

Info

Publication number
RU93048539A
RU93048539A RU93048539/04A RU93048539A RU93048539A RU 93048539 A RU93048539 A RU 93048539A RU 93048539/04 A RU93048539/04 A RU 93048539/04A RU 93048539 A RU93048539 A RU 93048539A RU 93048539 A RU93048539 A RU 93048539A
Authority
RU
Russia
Prior art keywords
production
therapeutic use
action against
possessing anti
against obesity
Prior art date
Application number
RU93048539/04A
Other languages
English (en)
Other versions
RU2090564C1 (ru
Inventor
Фудзита Такаси
Есиока Такао
Есиока Синдзи
Фудзивара Тосихико
Хорикоси Хиройоси
Original Assignee
Санкио Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санкио Компани Лимитед filed Critical Санкио Компани Лимитед
Publication of RU93048539A publication Critical patent/RU93048539A/ru
Application granted granted Critical
Publication of RU2090564C1 publication Critical patent/RU2090564C1/ru

Links

Claims (1)

  1. Соединение формулы I
    Figure 00000001

    в которой R представляет собой алкильную группу; X является кислородом или серой; Y представляет собой атом водорода или группу формулы -A-COOH, в которой A представляет собой алкиленовую группу; Ar является арилом или замещенной арильной группой; и их фармацевтически приемлемые соли и эфиры используют для лечения или профилактики диабета, ожирения, гиперлипемии, гипергликемии, осложнений диабета, вызванных ожирением, гипертензии и остеопороза.
RU9393048539A 1992-08-31 1993-08-30 Производные оксазолидина, или их фармацевтически приемлемые соли, или сложные эфиры и способ их получения RU2090564C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23114092 1992-08-31
JP4-231140 1992-08-31

Publications (2)

Publication Number Publication Date
RU93048539A true RU93048539A (ru) 1996-05-20
RU2090564C1 RU2090564C1 (ru) 1997-09-20

Family

ID=16918916

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9393048539A RU2090564C1 (ru) 1992-08-31 1993-08-30 Производные оксазолидина, или их фармацевтически приемлемые соли, или сложные эфиры и способ их получения

Country Status (22)

Country Link
US (1) US5436257A (ru)
EP (1) EP0590793B1 (ru)
JP (1) JP3201891B2 (ru)
KR (1) KR940003955A (ru)
CN (1) CN1036588C (ru)
AT (1) ATE185564T1 (ru)
AU (1) AU663611B2 (ru)
CA (1) CA2105149A1 (ru)
CZ (1) CZ287027B6 (ru)
DE (1) DE69326736T2 (ru)
DK (1) DK0590793T3 (ru)
ES (1) ES2139633T3 (ru)
FI (1) FI933802A (ru)
GR (1) GR3031887T3 (ru)
HK (1) HK1011979A1 (ru)
HU (1) HUT67087A (ru)
IL (1) IL106839A (ru)
NO (1) NO302121B1 (ru)
NZ (1) NZ248532A (ru)
RU (1) RU2090564C1 (ru)
TW (1) TW318181B (ru)
ZA (1) ZA936324B (ru)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
NO303782B1 (no) * 1994-03-23 1998-08-31 Sankyo Co Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
JPH09136877A (ja) * 1995-06-16 1997-05-27 Takeda Chem Ind Ltd 複素環化合物、その製造法及び用途
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
CZ298812B6 (cs) 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
US6114526A (en) 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
CN1221417A (zh) * 1996-07-26 1999-06-30 雷迪博士研究基金会 具有抗糖尿病、降低血脂、抗高血压性能的噻唑烷二酮化合物,其制备方法及其药物组合物
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6498170B2 (en) 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
US6410734B1 (en) 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6525202B2 (en) 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
WO2006041921A2 (en) * 2004-10-05 2006-04-20 Auspex Pharmaceuticals, Inc. Preparation and uses of rhodanine derivatives
CA2766033C (en) * 2009-06-25 2016-09-20 Alkermes, Inc. Prodrugs of nh-acidic compounds
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
CA3092335A1 (en) 2018-03-05 2019-09-12 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS6242903A (ja) 1985-08-16 1987-02-24 Earth Chem Corp Ltd ハエ誘引剤
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
EP0295828A1 (en) * 1987-06-13 1988-12-21 Beecham Group Plc Novel compounds
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
JPH0231079A (ja) 1988-07-20 1990-02-01 Kubota Ltd 作業車の変速操作構造
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
US5143930A (en) 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
US5037842A (en) * 1990-06-05 1991-08-06 Pfizer Inc. Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023583D0 (en) 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Similar Documents

Publication Publication Date Title
RU93048539A (ru) Производные оксазолидина, обладающие противодиабетическими свойствами и действием против ожирения, их получение и терапевтическое применение
RU92004433A (ru) Ароматические аминоспиртовые производные, способ их получения и фармацевтическая композиция
ES2139633T3 (es) Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
NO940610L (no) Oksazolidinedionderivater, deres fremstilling og anvendelse
NO792119L (no) Analogifremgangsmaate for fremstilling av 2-(2-alkoksyetyl)-2`hydroksyl-6,7-benzomorfaner og syreaddisjonssalter derav
ES8606336A1 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
RU92016545A (ru) Гетероциклические соединения, способ их получения и фармацевтическая композиция
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
KR920019352A (ko) 리노바이러스(Rhinoviruses)에 의한 감염 치료에 적합한 합성 화합물
ATE153666T1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
FI881104A (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
EP0347902A3 (en) Pyrrolecarboxylic acid derivatives
IL90559A0 (en) Analgetic derivatives of phenothiazine
KR930702978A (ko) 인식력 장애의 치료
ES477076A1 (es) Un procedimiento de preparacion de derivados de acido 1-naf-til-acetico.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
KR970701542A (ko) 안압 저하제(ocular tension depressant)
DE68902576D1 (de) Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet.
CA2011143A1 (en) Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
GB1565413A (en) Sulphur-containing n-(o-nitro-benzyl)-amino acids adn esters
JPS5481260A (en) 2-4-(3-methyl-2-thienyl)phenyl propionic acid, its nontoxic salt and antiphlogistics, analgesics, and antirheumatics containing them
DK260982A (da) Fremgangsmaade til fremstilling af 4"-deoxy-4"-acylamidoderivater af erythromycylamin og erythromycyliminderivater til anvendelse som mellemprodukter